Reference-scaled Bioequivalence Documentation
Reference-Scaled Bioequivalence Documentation is a regulatory documentation framework that, as a genus, belongs to the class of bioequivalence assessment protocols, and, by differentia, is distinguished by its incorporation of scaled bioequivalence criteria wherein the acceptance limits for average bioequivalence are dynamically adjusted based on the within-subject variability of the reference product.
2
Publications
39
Citations
7
Authors
5
Institutions
Publications per year
2017–2026
1
2
Yifan Zhang, Yunbiao Tang, Youming Lu et al. · Drug Design Development and Therapy · 2017 · 14 citations · Full text
1–3 of 2
7
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 7
5
Semmelweis University
Budapest, Hungary
1 h-index
1 publications
25 citations
Shanghai Institute of Materia Medica
Pudong, China
1 h-index
5 publications
70 citations
General Hospital of Shenyang Military Region
Shenyang, China
1 h-index
1 publications
14 citations

University of Toronto
Toronto, Canada
1 h-index
1 publications
25 citations
Canada Research Chairs
Ottawa, Canada
1 h-index
1 publications
25 citations
MedPharm (United Kingdom)
Guildford, United Kingdom
1 publications
13 citations

University of Coimbra
Coimbra, Portugal
1 publications
13 citations
Escola Superior de Saúde Egas Moniz
Caparica, Portugal
1 publications
13 citations
1–8 of 5
1 publications · 14 citations
1
h-index
AAPSJ · 1 publications · 25 citations
1
h-index
1 publications · 13 citations
1–3